SABRIL (vigabatrin) is a prescription medication utilized with various other treatments in children and adults 2 years old and older with refractory complex partial seizures (CPS) that have not responded well enough to several various other treatments and if the feasible benefits exceed the risk of vision loss.
It is suggested that your healthcare provider test your (or your child's) vision prior to or within 4 weeks after beginning SABRIL and a minimum of every 3 months during therapy until SABRIL is quit. If you or your youngster have any kind of side impact that bothers you or that does not go away, inform your health care carrier.
Tell your healthcare provider if you are expecting or mean to obtain pregnant. If vision screening can not be done, your doctor might proceed suggesting SABRIL, but will certainly not be able to watch for any kind of vision loss. If vision examinations are not done frequently, your doctor may quit recommending SABRIL for you (or your youngster).